Luciano Mutti
Prof. Luciano Mutti is one of the world’s leading experts on mesothelioma and asbestos-related diseases.
He graduated with honours in medicine from the University of Genoa, his hometown, where he also obtained his first specialisation in Respiratory Medecine.
After gaining experience in Italy, he began a long and successful career abroad, in England and Ireland, where he was recognised as a specialist in oncology by the Royal College of Physicians of Ireland.
He worked as a consultant in oncology at prestigious institutions such as St James’s Hospital in Dublin, Oxford University Hospital and North Middlesex University Hospital in London.
From 2014 to 2018, he held the Chair of Cancer Research at Salford University in Manchester, and in 2019 he became Professor of Translational Oncology at Temple University in Philadelphia.
In 2022, he returned to Italy to take up the position of Professor of Oncology at the University of L’Aquila and Director of the Department of Oncology at San Salvatore Hospital.
Retired from the Italian public University and National Health Service since November 2025, he continues his teaching, research and clinical activities in various institutions in Italy, England and the United States.
He is the author of approximately 200 internationally peer reviewed scientific publications, mostly on mesothelioma, which he has been studying for over 30 years. The current front-line therapies for asbestos-related cancers derive from the clinical and pre-clinical research of his group, which boasts prestigious collaborations around the world.
Alcase has included him in its list of 100 excellent doctors in the diagnosis and treatment of lung cancer https://alcase.it/support/medici-eccellenti/mutti-luciano/
He is also the Italian author of the official European guidelines for mesothelioma research and treatment https://pubmed.ncbi.nlm.nih.gov/32451346/ as well as the European guidelines on the standardisation of criteria for the recognition of lung cancer treatment centres https://pubmed.ncbi.nlm.nih.gov/30361252/ and those for the definition of quality criteria for the care of lung cancer patients.